MedPage Today8h
16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surge
Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...
CBS19 News9h
Virginia Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Gwinnett Daily Post9h
Georgia Has the 5th Highest Rate of GLP-1 Use in the Nation
and tirzepatide (branded as Mounjaro and Zepbound) work by mimicking a natural hormone that regulates both appetite and blood ...
KSJB AM10h
U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use
and tirzepatide (branded as Mounjaro and Zepbound) work by mimicking a natural hormone that regulates both appetite and blood ...
The Manhattan Mercury11h
Kansas Residents Are Using GLP-1s at an Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Southern Minn11h
Iowa Has the 9th Highest Rate of GLP-1 Use in the Country
and tirzepatide (branded as Mounjaro and Zepbound) work by mimicking a natural hormone that regulates both appetite and blood ...
Southern Minn11h
Minnesota Has the 13th Lowest Rate of GLP-1 Use in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Iosco County News-Herald11h
Michigan Residents Are Using GLP-1s at the 6th Highest Rate in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
The Digital Courier11h
North Carolina Residents Are Using GLP-1s at a Slightly Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Stoneham Independent12h
Massachusetts Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...